Jane Street’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-144,311
Closed -$12.3M 8509
2020
Q3
$12.3M Sell
144,311
-303,247
-68% -$15.3M 0.01% 1077
2020
Q2
$15.9M Buy
447,558
+401,843
+879% +$11.7M 0.01% 874
2020
Q1
$616K Buy
45,715
+19,990
+78% +$336K ﹤0.01% 3394
2019
Q4
$544K Sell
25,725
-965
-4% -$17K ﹤0.01% 3594
2019
Q3
$354K Buy
26,690
+2,485
+10% +$36.5K ﹤0.01% 3970
2019
Q2
$336K Sell
24,205
-41,274
-63% -$621K ﹤0.01% 4062
2019
Q1
$1.26M Buy
65,479
+30,356
+86% +$489K ﹤0.01% 2553
2018
Q4
$501K Buy
35,123
+25,395
+261% +$504K ﹤0.01% 3452
2018
Q3
$203K Buy
+9,728
New +$230K ﹤0.01% 4680
2018
Q2
Sell
-11,673
Closed -$235K 5885
2018
Q1
$171K Sell
11,673
-40,380
-78% -$660K ﹤0.01% 4502
2017
Q4
$841K Buy
52,053
+29,889
+135% +$353K ﹤0.01% 2550
2017
Q3
$310K Sell
22,164
-557
-2% -$5.55K ﹤0.01% 3644
2017
Q2
$201K Buy
+22,721
New +$160K ﹤0.01% 4033
2016
Q3
Sell
-62,529
Closed -$145K 4736
2016
Q2
$145K Buy
+62,529
New +$209K ﹤0.01% 3832
2014
Q4
Sell
-12,312
Closed -$46K 3223
2014
Q3
$46K Buy
+12,312
New +$41.6K ﹤0.01% 2427
2014
Q1
Sell
-46,098
Closed -$212K 3203
2013
Q4
$212K Buy
+46,098
New +$205K ﹤0.01% 1971
2013
Q3
Sell
-20,264
Closed -$110K 3279
2013
Q2
$110K Buy
+20,264
New +$66.6K ﹤0.01% 2423

Jane Street's IMMU Position: Q4 2020 in Review

Jane Street sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 144,311 shares — an estimated $12.3M sold.

Jane Street first reported a position in IMMU in Q2 2013 and held it in 17 quarters. The position peaked at $15.9M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Jane Street reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Jane Street sold 144,311 Immunomedics Inc shares in Q4 2020, an estimated $12.3M.
  • Jane Street first reported a position in Immunomedics Inc in Q2 2013 and held it in 17 quarters.
  • Jane Street's Immunomedics Inc position peaked at $15.9M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Jane Street's 13F filing for Q4 2020, filed 17 Feb 2021.